down arrow

Jazz Pharmaceuticals Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IE00B4Q5ZN47
USD
166.91
0.2 (0.12%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
4,068.95
3,834.20
3,659.37
3,094.24
2,363.57
2,161.76
1,890.92
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,068.95
3,834.20
3,659.37
3,094.24
2,363.57
2,161.76
1,890.92
Raw Material Cost
1,073.03
1,043.86
1,139.69
966.53
408.50
482.74
323.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
339.60
351.12
297.10
278.08
96.31
92.76
77.33
Selling and Distribution Expenses
1,385.29
1,281.40
1,209.07
1,222.68
854.23
736.94
683.03
Other Expenses
54.44
49.85
29.34
22.77
23.91
20.70
14.93
Total Expenditure (Excl Depreciation)
3,342.32
3,174.92
2,939.21
2,694.96
1,598.11
1,519.41
1,232.69
Operating Profit (PBDIT) excl Other Income
726.5999999999999
659.3000000000001
720.1999999999999
399.3
765.5
642.3000000000001
658.1999999999999
Other Income
107.77
56.92
10.44
14.55
-26.52
20.88
-7.38
Operating Profit (PBDIT)
1,494.47
1,354.90
1,360.08
966.31
1,017.20
1,033.39
867.59
Interest
339.60
351.12
297.10
278.08
96.31
92.76
77.33
Exceptional Items
-24.44
-67.16
-806.30
-248.59
-367.55
-116.17
-44.07
Gross Profit (PBDT)
2,995.92
2,790.34
2,519.69
2,127.71
1,955.07
1,679.02
1,567.88
Depreciation
660.07
638.70
629.47
552.48
278.25
370.16
216.73
Profit Before Tax
470.35
297.93
-372.78
-112.84
275.10
454.30
529.46
Tax
-91.43
-119.91
-158.65
216.12
33.52
-73.15
80.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
560.12
414.83
-224.06
-329.67
238.62
523.37
447.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
560.12
414.83
-224.06
-329.67
238.62
523.37
447.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
560.12
414.83
-224.06
-329.67
238.62
523.37
447.10
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
4,093.76
3,737.00
3,085.73
3,965.19
3,659.74
3,110.98
2,757.42
Earnings per share (EPS)
8.65
6.1
-3.58
-5.52
4.22
9.09
7.3
Diluted Earnings per share
8.65
6.1
-3.58
-5.52
4.22
9.09
7.3
Operating Profit Margin (Excl OI)
17.86%
17.19%
19.68%
12.9%
32.39%
29.71%
34.81%
Gross Profit Margin
27.78%
24.43%
7.01%
14.21%
23.41%
38.14%
39.46%
PAT Margin
13.77%
10.82%
-6.12%
-10.65%
10.1%
24.21%
23.64%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 6.12% vs 4.78% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 35.03% vs 285.10% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 6.83% vs -3.82% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -3.28% vs 18.18% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Jazz Pharmaceuticals Plc With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
4,068.95
29.05
4,039.90
13,906.71%
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,068.95
29.05
4,039.90
13,906.71%
Raw Material Cost
1,073.03
8.24
1,064.79
12,922.21%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
339.60
0.00
339.60
Selling and Distribution Expenses
1,385.29
584.08
801.21
137.17%
Other Expenses
54.44
55.04
-0.60
-1.09%
Total Expenditure (Excl Depreciation)
3,342.32
1,142.73
2,199.59
192.49%
Operating Profit (PBDIT) excl Other Income
726.63
-1,113.68
1,840.31
165.25%
Other Income
107.77
361.15
-253.38
-70.16%
Operating Profit (PBDIT)
1,494.47
-745.20
2,239.67
300.55%
Interest
339.60
0.00
339.60
Exceptional Items
-24.44
70.94
-95.38
-134.45%
Gross Profit (PBDT)
2,995.92
20.81
2,975.11
14,296.54%
Depreciation
660.07
7.33
652.74
8,905.05%
Profit Before Tax
470.35
-681.59
1,151.94
169.01%
Tax
-91.43
48.17
-139.60
-289.81%
Provisions and contingencies
0
0
0.00
Profit After Tax
560.12
-545.01
1,105.13
202.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
560.12
-545.01
1,105.13
202.77%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-184.75
184.75
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
560.12
-729.76
1,289.88
176.75%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
4,093.76
4,687.60
-593.84
-12.67%
Earnings per share (EPS)
8.65
-0.24
8.89
3,704.17%
Diluted Earnings per share
8.65
-0.24
8.89
3,704.17%
Operating Profit Margin (Excl OI)
17.86%
-3,833.27%
0.00
3,851.13%
Gross Profit Margin
27.78%
-2,320.79%
0.00
2,348.57%
PAT Margin
13.77%
-1,875.92%
0.00
1,889.69%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 406.89 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.12% vs 4.78% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 56.01 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 35.03% vs 285.10% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 138.67 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.83% vs -3.82% in Dec 2023

Annual - Interest
Interest 33.96 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -3.28% vs 18.18% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.86%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."